Extra corporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO-CS): rationale and design of the multicenter randomized trial.

@article{Ostadal2017ExtraCM,
  title={Extra corporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO-CS): rationale and design of the multicenter randomized trial.},
  author={Petr Ostadal and Richard Rokyta and Andreas Krűger and Dagmar Vondr{\'a}kov{\'a} and Marek Janotka and Ondřej {\vS}m{\'i}d and Jana {\vS}malcov{\'a} and Milan Hrom{\'a}dka and Ale{\vs} Linhart and Jan Bělohl{\'a}vek},
  journal={European journal of heart failure},
  year={2017},
  volume={19 Suppl 2},
  pages={124-127}
}
AIMS Extracorporeal membrane oxygenation (ECMO) in veno-arterial configuration represents an increasingly used method for circulatory support. ECMO in cardiogenic shock offers rapid improvement of circulatory status and significant increase in tissue perfusion. Current evidence on the use of ECMO in cardiogenic shock remains insufficient. The aim of the… CONTINUE READING